AJOVista’s Alpine Immune Sciences Inc ALPN Stock Holding History

AJOVista’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,371	Closed	-$64.3K	–	451
2023 Q4	$64.3K	Buy	+3,371	New	+$46.8K	0.08%	250

Other funds holding ALPN

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

AJOVista's ALPN Position: Q1 2024 in Review

AJOVista sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2024, closing a stake of 3,371 shares — an estimated $64.3K sold.

AJOVista first reported a position in ALPN in Q4 2023 and held it in 1 quarter. The position peaked at $64.3K in Q4 2023. 180 funds tracked by Wall St. Rank hold ALPN as of Q1 2024.

AJOVista reported no remaining Alpine Immune Sciences Inc position as of Q1 2024 after selling out during the quarter.
AJOVista sold 3,371 Alpine Immune Sciences Inc shares in Q1 2024, an estimated $64.3K.
AJOVista first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 1 quarter.
AJOVista's Alpine Immune Sciences Inc position peaked at $64.3K in Q4 2023.
180 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.